The current ADA guidelines include recommendations for screening and diagnosis of prediabetes and diabetes are seen in Table 3. The ADA recommends using any of these criteria for prediabetes and diabetes diagnosis.
Table 3. Criteria for the Screening and Diagnosis of Prediabetes and Diabetes.
| Prediabetes | Diabetes |
A1C | 5.7–6.4% (39–47 mmol/mol) | ≥6.5% (48 mmol/mol)† |
Fasting plasma glucose (FPG) | 100–125 mg/dL (5.6–6.9 mmol/L) | ≥126 mg/dL (7.0 mmol/L)† |
2-hour plasma glucose during 75-g OGTT | 140–199 mg/dL (7.8–11.0 mmol/L) | ≥200 mg/dL (11.1 mmol/L)† |
Random plasma glucose | N/A | ≥200 mg/dL (11.1 mmol/L)‡ |
†In the absence of unequivocal hyperglycemia, diagnosis requires two abnormal test results (e.g., A1C and FPG) from the same sample or in two separate samples.
‡Only diagnostic in a patient with classic symptoms of hyperglycemia or hyperglycemic crisis.